pharmaphorum
OCTOBER 23, 2020
Novartis is opening a new digital health innovation hub in Canada to help develop “scalable, digital solutions” for patients and healthcare providers. The Canadian Biome Digital Innovation Hub will be based in Montreal at the artificial intelligence research institute, Mila. The institute formed a strategic alliance with Novartis in 2019. Canada is the latest country to join a global network of hubs opened by Novartis.
Outsourcing Pharma
OCTOBER 8, 2020
A veteran with more than 20 years of experience talks about the vitality of recruiting an inclusive patient population, and the perils of falling short.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharma Marketing Network
OCTOBER 13, 2020
Below is a Q&A with Mark Bard, Co-Founder of The DHC Group, who offers his insights on the challenges COVID-19 has brought to pharma, as well as what innovation is taking place due to this full shift to digital and what lies ahead in the future. What is the most challenging aspect of COVID-19 for the industry? Mark Bard: I think the most challenging aspect of the current situation is the inability of anyone – patient, physician, payor, or pharma – to truly predict how long it will take for v
Druggist
OCTOBER 8, 2020
In today’s post, I will contrast the two most popular proton pump inhibitors (PPIs) prescribed in the UK. Not only lansoprazole and omeprazole are the two most common PPI, but they are also one of the most popular prescribed drugs in the UK. I will review the essential facts to highlight the similarity and difference between each medication. Lansoprazole vs omeprazole – post summary: Lansoprazole vs omeprazole: drug classification Lansoprazole vs omeprazole: mechanism of action Lansoprazol
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharma Tutor
OCTOBER 2, 2020
About Author. Nrusingha Panda. Department of Quality Assurance, Mankind Pharma Ltd., Bermiok Elaka, South Sikkim, Sikkim, Zip Code- 737126, India. ABSTRACT. Regulatory authorities expect from pharmaceutical industries that there should be written and approved procedures of sampling to collect samples for testing before approval of components of drug products, container and closure of drug products and drug product itself to assure patient safety in all respects whether chemical, physical and bio
Pharma Mirror
OCTOBER 22, 2020
By Rotem Shor, Medisafe Chief Technology Officer Technology and health have experienced a convergence in the last few years, leading to a new state of digital health that is transforming how we live and work. But there is a greater science behind it that analyzes tremendous amounts of data to shape and personalize our health. The post Using Behavioral Science in A Digital World appeared first on Pharma Mirror Magazine.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Outsourcing Pharma
OCTOBER 30, 2020
In order to effectively handle collection and analysis of huge volumes of vital data, a leader from IQVIA advises bringing on people up to the challenge.
Pharma Marketing Network
OCTOBER 5, 2020
An interview with Mark Bard, Co-Founder of The DHC Group and Justin Grossman, CEO/Managing Partner, meltmedia. In response to this week’s DHC Virtual Summit with Novartis, Mark Bard, Co-founder/Managing Partner, DHC, talked one-on-one with Justin Grossman about how the COVID pandemic will change the world of digital healthcare marketing. Here are some highlights from their discussion.
Druggist
OCTOBER 21, 2020
Fungal nail infection is a common condition, which usually affects toenails. The main products used for toenail fungus treatment are available in most pharmacies, supermarkets and perhaps with the best range of products found online. Topical products, which are applied directly to the infected area, are the main products used as toenail fungus treatment.
Pharma Tutor
OCTOBER 1, 2020
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharma Mirror
OCTOBER 6, 2020
One of the biggest medical advancements of recent times is the invention of the cell isolation method. Also known as cell sorting or cell separation, the cell isolation method has rapidly become an integral component of modern biological and medical research. In this method, a one-cell population or multiple cell types are isolated from a. The post How is Cell Isolation Revolutionizing Medical Industry?
pharmaphorum
OCTOBER 22, 2020
Cancer doesn’t end when treatment stops – it’s a lifelong journey and people need support throughout, says patient advocate Megan-Claire Chase. No one gets through cancer unscathed. People are usually left with a mixture of treatment aftereffects, toxic positivity, and lingering anger to deal with. Megan-Claire Chase , a fierce patient advocate who has been blogging about her experiences since she was diagnosed with breast cancer in 2015, said the disease never went away.
Outsourcing Pharma
OCTOBER 19, 2020
The agencyâs Solidarity Therapeutics Trial examined a range of drugs repurposed for COVID-19 treatment, finding nearly no effect on patient mortality.
Pharma Marketing Network
OCTOBER 5, 2020
An interview with Mark Bard, Co-Founder of The DHC Group and Justin Grossman, CEO/Managing Partner, meltmedia. In response to this week’s DHC Virtual Summit with Novartis, Mark Bard, Co-founder/Managing Partner, DHC, talked one-on-one with Justin Grossman about how the COVID pandemic will change the world of digital healthcare marketing. Here are some highlights from their discussion.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharma Times
OCTOBER 28, 2020
Acquisition will enable Base Genomics to accelerate clinical and commercial development
Druggist
OCTOBER 4, 2020
Irritable bowel syndrome (IBS) is a common condition which is characterised by smooth muscle spasm alongside the gastrointestinal tract with a range of associated symptoms. Patients who are diagnosed with IBS are usually advised on the lifestyles to minimise the risk of IBS symptoms. Review of diet and lifestyle is one of the first recommendations gives by a doctor once a patient is diagnosed with IBS.
Pharma Mirror
OCTOBER 30, 2020
The sneeze guard has been keeping employees at public counters, and food on display, safe from contagious diseases for a long time now, so it’s most certainly not a new invention. However, the need to install a sneeze guard in hospitals, pharmacies and other healthcare facilities is an absolute must in 2020 and beyond. Keeping. The post Why Sneeze Guards are Not Optional Anymore appeared first on Pharma Mirror Magazine.
pharmaphorum
OCTOBER 1, 2020
A digital tool that allows doctors to monitor patients with COVID-19 remotely in real time and intervene when treatment is needed has been launched in the UK. The mobile app – developed by digital heath specialist Careology – provides advice on COVID-19 symptoms and links patients with doctors at the London General Practice, a private GP group with around 50,000 people on its books, via online video consultations.
Outsourcing Pharma
OCTOBER 12, 2020
Technology impacting generic drugs include artificial intelligence, telemedicine, fraud-preventing digital solutions and more, according to a report.
Pharma Marketing Network
OCTOBER 9, 2020
Just a little more than seven months ago, pharma, agencies, vendors, physicians, pharmacists, patients, and medical supply chains in the U.S. and across the world were caught in a whirlwind of groundlessness and anxiety as Covid -19’s spread quickly enveloped much of the planet. Such a shock to the system required a lot of intense, focused learning to keep the industry up and running, to keep all of healthcare’s stakeholders connected, to continue the mission to safeguard and preserve health.
Pharma Times
OCTOBER 21, 2020
Pharmaceutical and life sciences industries are growing in importance across country
Druggist
OCTOBER 30, 2020
In a pharmacy, patients request a pain relief medication due to a toothache quite commonly. Seeing a dentist to investigate the cause of pain is crucial. In the meantime, the patient may consider the use of over the counter medicines to manage the pain. Although it is difficult to point out a single best pain reliever for toothache, patients may see pain reduction with any of the drugs reviewed below.
pharmaphorum
OCTOBER 26, 2020
Preventive care programmes are key to better health outcomes, but several factors are limiting their uptake. A new analysis looks at these barriers and asks how they could be overcome. Over the past decade, many healthcare systems have worked to expand their focus on health maintenance and disease prevention as several studies have indicated that preventive care services can play a significant role in improving general health while helping reduce long term healthcare costs.
pharmaphorum
OCTOBER 19, 2020
As part of our series of opinion pieces from leaders at Janssen, the company’s Maria Raad looks at how we can embrace tech and data science to overcome increasing pressures on healthcare systems. For the next generation born in the western world, living to be 100 will be the norm. While this seems like a desirable aspiration for our grandchildren, it adds new pressures on our healthcare systems.
pharmaphorum
OCTOBER 6, 2020
An Excel spreadsheet was behind IT glitch that caused thousands of positive COVID-19 tests to be omitted from the UK’s official records, according to press reports. The issue that left almost 16,000 positive results going unreported has been blamed on the way Public Health England tracks results from mainly private labs that have been hired to add extra testing capacity.
pharmaphorum
OCTOBER 30, 2020
Since entering the pharmaceutical industry as a graduate trainee in the late 1990s, Asad Mohsin Ali’s career has taken him across the business from Novartis, MSD and Tesaro, before joining global biopharma Ipsen. He tells us how the company has responded to COVID and how he’d like to see the UK industry grow in the future. As managing director, Ipsen UK & Ireland, Ali heads up one of Ipsen’s three global hubs, as well as chairing a UK & Ireland Site Steering Committee overseeing 900 peop
pharmaphorum
OCTOBER 19, 2020
Gilead Sciences’ Kite Pharma unit is closing on approval of its second European approval for a CAR-T for cancer, after the CHMP backed its Tecartus therapy for mantle cell lymphoma. The EMA’s human drugs advisory committee recommended approval of Tecartus (brexucabtagene autoleucel; formerly KTE-X19 ) for relapsed or refractory MCL setting up a formal approval by the regulator in the coming weeks.
pharmaphorum
OCTOBER 5, 2020
Digital health firm Your.MD has secured $30 million in a Series A round investment led by the consumer health giant Reckitt Benckiser (RB). Your.MD is the company behind the medical-grade, augmented intelligence self-care app Healthily, and will use the funding to accelerate the platform through a series of clinically-validated “health hubs”. Following a seed funding round led by RB and existing shareholders, the now completed Series A funding round will allow the app to reach other markets incl
pharmaphorum
OCTOBER 1, 2020
For a long time, venture capital (VC) firms have been controlled mainly by men. But things are changing and women are becoming more influential in life sciences VCs, with an increase in business going to all-female teams. We spoke with two female VC leaders about how women could act as agents for change in this male-dominated world. Last year saw a record amount of venture capital – $17.2 billion – raised by women, according to the financial information company Pitchbook.
pharmaphorum
OCTOBER 2, 2020
Psychedelic therapy company Field Trip Psychedelics has announced that it will soon join the growing list of psychedelic companies going public. . Through a direct listing on the CSE, the company expects trading to begin on 7 October after entering into an amalgamation agreement in August with Newton Energy Corp. Field Trip aims to “take a personalised approach to mental wellness” by blending legal psychedelic-enhanced therapy, mindfulness, and self-care with a series of sessions with trained ps
pharmaphorum
OCTOBER 16, 2020
Patients with heart failure often have a dismal prognosis as the condition usually worsens over time, but a new study aims to see if digital health technologies can improve their prospects. The trial – run by Boehringer Ingelheim and Yale University – will test a smart bathroom scale device that has cardiac monitoring built in, as well as an app to help patients improve their diet and lose weight and a digital assistant designed to motivate them to actively manage their health.
pharmaphorum
OCTOBER 28, 2020
Claus Møldrup explores research showing that patients want their voice to be heard more by pharma, and asks what a truly effective feedback loop for medicines might look like. The democratisation of data opens up improvements to virtually every product and service across virtually every sector — bar one. Pharma remains stubbornly closed to feedback, with potentially damaging consequences for the industry, healthcare systems and patients.
pharmaphorum
OCTOBER 27, 2020
Analysing real-world health data could help overcome the bias towards men in traditional medical research, says Sensyne Health’s Dr Lucy Mackillop. Collecting and analysing anonymised patient data has the potential to generate valuable insights that can catalyse research, lead to improved patient care, and power the development of new treatments.
pharmaphorum
OCTOBER 13, 2020
Ayming Group’s second annual International Innovation Barometer (IIB) has said that the international outlook for R&D is “remarkably promising” despite strong headwinds caused by COVID-19. The report reveals that R&D departments are being empowered by the creation of ‘innovation ecosystems’, new funding methods, and the deployment of technology.
Expert insights. Personalized for you.
141 
Let's personalize your content